CP and hepatocellular carcinoma: Accordingly, the levels of E2F1 were significantly increased in TACO expressing HCC tissue (Fig. 5b, Supplementary Fig. S2c), suggesting that HBV CP mutations may induce hepatocarcinogenesis and tumour progression via similar mechanisms.